Boston Strategics (BSC) has started a Phase I clinical trial of Fujifilm's anti-cancer agent FF-10501 in the US to treat...
Read moreUS-based biopharmaceutical firm Exelixis has reported disappointing top-line results from the final analysis of COMET-1, the Phase III trial of...
Read moreThe US Food and Drug Administration (FDA) has granted clearance to Asterias Biotherapeutics for the initiation of a Phase I/IIa...
Read moreAlexion Pharmaceuticals, Inc. today announced the initiation of dosing in a single, multinational, placebo-controlled clinical trial to evaluate the efficacy...
Read moreOncoGenex Pharmaceuticals, Inc. announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of non-small cell lung...
Read moreOramed Pharmaceuticals has started recruiting patients for a new clinical trial of ORMD-0801, an orally ingestible insulin capsule, for patients...
Read moreGermany-based Boehringer Ingelheim has enrolled the first patients in its new RE-DUAL PCI international phase III study to evaluate dabigatran...
Read more
By: Margaret A. Hamburg, M.D.Margaret A. Hamburg, M.D., is Commissioner of the U.S. Food and Drug Administration August...
Read moreCAZ-AVI treated patients with cIAI as effectively as meropenem CAZ-AVI also treated cIAI patients infected with ceftazidime-resistant bacteria as...
Read moreCoherus BioSciences, Inc. ("Coherus") today announced that CHS-1420, its proposed biosimilar of adalimumab (Humira®), met the primary endpoint in a...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
